nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—NEU2—Sialic acid metabolism—NEU1—epilepsy syndrome	0.0189	0.0623	CbGpPWpGaD
Zanamivir—NEU2—Glycosphingolipid metabolism—NEU1—epilepsy syndrome	0.0166	0.0545	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—CERS1—epilepsy syndrome	0.0148	0.0487	CbGpPWpGaD
Zanamivir—NEU2—Sialic acid metabolism—ST3GAL3—epilepsy syndrome	0.0146	0.0482	CbGpPWpGaD
Zanamivir—NEU2—Glycosphingolipid metabolism—ASAH1—epilepsy syndrome	0.0145	0.0477	CbGpPWpGaD
Zanamivir—NEU2—Sialic acid metabolism—ST3GAL5—epilepsy syndrome	0.0141	0.0463	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—NEU1—epilepsy syndrome	0.0132	0.0433	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—NEU1—epilepsy syndrome	0.0107	0.0354	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—NEU1—epilepsy syndrome	0.0103	0.0338	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—ST3GAL3—epilepsy syndrome	0.0102	0.0335	CbGpPWpGaD
Zanamivir—NEU2—Synthesis of substrates in N-glycan biosythesis—ST3GAL5—epilepsy syndrome	0.00978	0.0322	CbGpPWpGaD
Zanamivir—NEU2—Sphingolipid metabolism—ASAH1—epilepsy syndrome	0.00896	0.0295	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—ST3GAL3—epilepsy syndrome	0.00831	0.0274	CbGpPWpGaD
Zanamivir—NEU2—Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein—ST3GAL5—epilepsy syndrome	0.00798	0.0263	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—NEU1—epilepsy syndrome	0.00683	0.0225	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—ST3GAL3—epilepsy syndrome	0.00528	0.0174	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—PIGN—epilepsy syndrome	0.0051	0.0168	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—PIGT—epilepsy syndrome	0.0051	0.0168	CbGpPWpGaD
Zanamivir—NEU2—Asparagine N-linked glycosylation—ST3GAL5—epilepsy syndrome	0.00508	0.0167	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—NEU1—epilepsy syndrome	0.00353	0.0116	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—PIGA—epilepsy syndrome	0.00328	0.0108	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—VDAC1—epilepsy syndrome	0.00319	0.0105	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CERS1—epilepsy syndrome	0.0028	0.00922	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—FAR1—epilepsy syndrome	0.0028	0.00922	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ST3GAL3—epilepsy syndrome	0.00273	0.009	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—ST3GAL5—epilepsy syndrome	0.00263	0.00864	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PIGN—epilepsy syndrome	0.00242	0.00796	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PIGT—epilepsy syndrome	0.00242	0.00796	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—GOSR2—epilepsy syndrome	0.00221	0.00728	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—SLCO1A2—epilepsy syndrome	0.00212	0.00698	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ERN1—epilepsy syndrome	0.00206	0.00677	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—NEU1—epilepsy syndrome	0.00194	0.00639	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—HSD17B4—epilepsy syndrome	0.00187	0.00615	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ASAH1—epilepsy syndrome	0.0017	0.00558	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—NEU1—epilepsy syndrome	0.00168	0.00552	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF2AK3—epilepsy syndrome	0.00168	0.00552	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CA13—epilepsy syndrome	0.00164	0.00542	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PIGA—epilepsy syndrome	0.00156	0.00513	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—TPP1—epilepsy syndrome	0.00156	0.00513	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF2B5—epilepsy syndrome	0.00147	0.00482	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ADD1—epilepsy syndrome	0.00139	0.00457	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—TXNRD1—epilepsy syndrome	0.00132	0.00436	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ST3GAL3—epilepsy syndrome	0.0013	0.00427	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CERS1—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PDXK—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—FAR1—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GLUD1—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—L2HGDH—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ADK—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ST3GAL5—epilepsy syndrome	0.00125	0.0041	CbGpPWpGaD
Zanamivir—NEU2—Post-translational protein modification—PLAUR—epilepsy syndrome	0.00124	0.00409	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ATP6AP2—epilepsy syndrome	0.00118	0.00389	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GAMT—epilepsy syndrome	0.00114	0.00375	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—EPM2A—epilepsy syndrome	0.00114	0.00375	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NHLRC1—epilepsy syndrome	0.00114	0.00375	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PNPO—epilepsy syndrome	0.00114	0.00375	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CA4—epilepsy syndrome	0.00106	0.00349	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—QDPR—epilepsy syndrome	0.00106	0.00349	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—COX3—epilepsy syndrome	0.000997	0.00328	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLCO1A2—epilepsy syndrome	0.000945	0.00311	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PFKL—epilepsy syndrome	0.000945	0.00311	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—KCNB1—epilepsy syndrome	0.000945	0.00311	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CACNA2D2—epilepsy syndrome	0.000945	0.00311	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—SLC6A8—epilepsy syndrome	0.000945	0.00311	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	0.000923	0.00304	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	0.000918	0.00302	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NEU1—epilepsy syndrome	0.000864	0.00284	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—UPB1—epilepsy syndrome	0.000864	0.00284	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ATIC—epilepsy syndrome	0.000864	0.00284	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—HSD17B4—epilepsy syndrome	0.000832	0.00274	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PPP1R3C—epilepsy syndrome	0.000803	0.00264	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GBE1—epilepsy syndrome	0.000803	0.00264	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—EIF2S1—epilepsy syndrome	0.000798	0.00263	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—ACTB—epilepsy syndrome	0.000788	0.00259	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	0.000785	0.00258	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ASAH1—epilepsy syndrome	0.000755	0.00249	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—STXBP1—epilepsy syndrome	0.000735	0.00242	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—NT5E—epilepsy syndrome	0.000716	0.00236	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALAD—epilepsy syndrome	0.000716	0.00236	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CACNA1A—epilepsy syndrome	0.000683	0.00225	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ALDH7A1—epilepsy syndrome	0.000683	0.00225	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—BCHE—epilepsy syndrome	0.000678	0.00223	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ST3GAL3—epilepsy syndrome	0.000668	0.0022	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—ADSL—epilepsy syndrome	0.000655	0.00216	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—GLUL—epilepsy syndrome	0.000642	0.00211	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CACNA1D—epilepsy syndrome	0.00063	0.00208	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—PLAUR—epilepsy syndrome	0.00059	0.00194	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—TXNRD1—epilepsy syndrome	0.00059	0.00194	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AQP1—epilepsy syndrome	0.000572	0.00188	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	0.00055	0.00181	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—CHRM3—epilepsy syndrome	0.000518	0.0017	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—KCNJ11—epilepsy syndrome	0.000518	0.0017	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	0.000482	0.00159	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	0.000472	0.00155	CbGpPWpGaD
Zanamivir—Rash—Propofol—epilepsy syndrome	0.000438	0.00063	CcSEcCtD
Zanamivir—Dermatitis—Propofol—epilepsy syndrome	0.000438	0.000629	CcSEcCtD
Zanamivir—Headache—Propofol—epilepsy syndrome	0.000436	0.000625	CcSEcCtD
Zanamivir—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000434	0.000624	CcSEcCtD
Zanamivir—Chills—Gabapentin—epilepsy syndrome	0.000433	0.000622	CcSEcCtD
Zanamivir—Vomiting—Midazolam—epilepsy syndrome	0.000432	0.000621	CcSEcCtD
Zanamivir—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000432	0.000621	CcSEcCtD
Zanamivir—Asthenia—Felbamate—epilepsy syndrome	0.000432	0.00062	CcSEcCtD
Zanamivir—Myalgia—Valproic Acid—epilepsy syndrome	0.000431	0.00062	CcSEcCtD
Zanamivir—Arthralgia—Valproic Acid—epilepsy syndrome	0.000431	0.00062	CcSEcCtD
Zanamivir—Anxiety—Valproic Acid—epilepsy syndrome	0.00043	0.000618	CcSEcCtD
Zanamivir—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000429	0.000616	CcSEcCtD
Zanamivir—Rash—Midazolam—epilepsy syndrome	0.000429	0.000616	CcSEcCtD
Zanamivir—Dizziness—Fosphenytoin—epilepsy syndrome	0.000429	0.000616	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000428	0.000615	CcSEcCtD
Zanamivir—Dermatitis—Midazolam—epilepsy syndrome	0.000428	0.000615	CcSEcCtD
Zanamivir—Urticaria—Carbamazepine—epilepsy syndrome	0.000428	0.000614	CcSEcCtD
Zanamivir—Vomiting—Levetiracetam—epilepsy syndrome	0.000427	0.000613	CcSEcCtD
Zanamivir—Discomfort—Valproic Acid—epilepsy syndrome	0.000426	0.000612	CcSEcCtD
Zanamivir—Headache—Midazolam—epilepsy syndrome	0.000426	0.000612	CcSEcCtD
Zanamivir—Abdominal pain—Carbamazepine—epilepsy syndrome	0.000426	0.000611	CcSEcCtD
Zanamivir—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000426	0.000611	CcSEcCtD
Zanamivir—Diarrhoea—Diazepam—epilepsy syndrome	0.000426	0.000611	CcSEcCtD
Zanamivir—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	0.000426	0.000611	CcSEcCtD
Zanamivir—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000425	0.000611	CcSEcCtD
Zanamivir—Sinusitis—Topiramate—epilepsy syndrome	0.000424	0.000609	CcSEcCtD
Zanamivir—Rash—Levetiracetam—epilepsy syndrome	0.000423	0.000608	CcSEcCtD
Zanamivir—Dermatitis—Levetiracetam—epilepsy syndrome	0.000423	0.000608	CcSEcCtD
Zanamivir—Asthenia—Zonisamide—epilepsy syndrome	0.000423	0.000607	CcSEcCtD
Zanamivir—NEU2—Metabolism—ABCG2—epilepsy syndrome	0.000422	0.00139	CbGpPWpGaD
Zanamivir—Agitation—Pregabalin—epilepsy syndrome	0.000421	0.000605	CcSEcCtD
Zanamivir—Headache—Levetiracetam—epilepsy syndrome	0.000421	0.000604	CcSEcCtD
Zanamivir—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000418	0.000601	CcSEcCtD
Zanamivir—Dizziness—Vigabatrin—epilepsy syndrome	0.000418	0.0006	CcSEcCtD
Zanamivir—Confusional state—Valproic Acid—epilepsy syndrome	0.000417	0.000599	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—AGT—epilepsy syndrome	0.000417	0.00137	CbGpPWpGaD
Zanamivir—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000416	0.000597	CcSEcCtD
Zanamivir—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000414	0.000594	CcSEcCtD
Zanamivir—Urticaria—Lamotrigine—epilepsy syndrome	0.000413	0.000594	CcSEcCtD
Zanamivir—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000413	0.000594	CcSEcCtD
Zanamivir—Malaise—Pregabalin—epilepsy syndrome	0.000413	0.000593	CcSEcCtD
Zanamivir—Nausea—Propofol—epilepsy syndrome	0.000413	0.000593	CcSEcCtD
Zanamivir—Vomiting—Fosphenytoin—epilepsy syndrome	0.000412	0.000592	CcSEcCtD
Zanamivir—Diarrhoea—Felbamate—epilepsy syndrome	0.000412	0.000592	CcSEcCtD
Zanamivir—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000411	0.000591	CcSEcCtD
Zanamivir—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000411	0.000591	CcSEcCtD
Zanamivir—Dizziness—Diazepam—epilepsy syndrome	0.000411	0.000591	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP2C19—epilepsy syndrome	0.000411	0.00135	CbGpPWpGaD
Zanamivir—Infection—Valproic Acid—epilepsy syndrome	0.000411	0.00059	CcSEcCtD
Zanamivir—Syncope—Pregabalin—epilepsy syndrome	0.000411	0.00059	CcSEcCtD
Zanamivir—Rash—Fosphenytoin—epilepsy syndrome	0.000409	0.000587	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP11A1—epilepsy syndrome	0.000409	0.00135	CbGpPWpGaD
Zanamivir—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000408	0.000586	CcSEcCtD
Zanamivir—Haemoglobin—Topiramate—epilepsy syndrome	0.000408	0.000586	CcSEcCtD
Zanamivir—Asthenia—Clonazepam—epilepsy syndrome	0.000408	0.000585	CcSEcCtD
Zanamivir—Headache—Fosphenytoin—epilepsy syndrome	0.000406	0.000583	CcSEcCtD
Zanamivir—Haemorrhage—Topiramate—epilepsy syndrome	0.000406	0.000583	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	0.000406	0.00134	CbGpPWpGaD
Zanamivir—Asthenia—Phenytoin—epilepsy syndrome	0.000405	0.000581	CcSEcCtD
Zanamivir—Nausea—Midazolam—epilepsy syndrome	0.000404	0.00058	CcSEcCtD
Zanamivir—Hallucination—Topiramate—epilepsy syndrome	0.000404	0.00058	CcSEcCtD
Zanamivir—Diarrhoea—Zonisamide—epilepsy syndrome	0.000403	0.000579	CcSEcCtD
Zanamivir—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000403	0.000578	CcSEcCtD
Zanamivir—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000403	0.000578	CcSEcCtD
Zanamivir—Vomiting—Vigabatrin—epilepsy syndrome	0.000402	0.000577	CcSEcCtD
Zanamivir—Skin disorder—Valproic Acid—epilepsy syndrome	0.000402	0.000577	CcSEcCtD
Zanamivir—Cough—Pregabalin—epilepsy syndrome	0.0004	0.000574	CcSEcCtD
Zanamivir—Nausea—Levetiracetam—epilepsy syndrome	0.000399	0.000573	CcSEcCtD
Zanamivir—Rash—Vigabatrin—epilepsy syndrome	0.000398	0.000572	CcSEcCtD
Zanamivir—Dizziness—Felbamate—epilepsy syndrome	0.000398	0.000572	CcSEcCtD
Zanamivir—Dermatitis—Vigabatrin—epilepsy syndrome	0.000398	0.000572	CcSEcCtD
Zanamivir—Convulsion—Pregabalin—epilepsy syndrome	0.000397	0.00057	CcSEcCtD
Zanamivir—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000397	0.00057	CcSEcCtD
Zanamivir—Headache—Vigabatrin—epilepsy syndrome	0.000396	0.000569	CcSEcCtD
Zanamivir—Vomiting—Diazepam—epilepsy syndrome	0.000396	0.000568	CcSEcCtD
Zanamivir—Anorexia—Valproic Acid—epilepsy syndrome	0.000394	0.000566	CcSEcCtD
Zanamivir—Rash—Diazepam—epilepsy syndrome	0.000392	0.000563	CcSEcCtD
Zanamivir—Dermatitis—Diazepam—epilepsy syndrome	0.000392	0.000563	CcSEcCtD
Zanamivir—Myalgia—Pregabalin—epilepsy syndrome	0.00039	0.00056	CcSEcCtD
Zanamivir—Arthralgia—Pregabalin—epilepsy syndrome	0.00039	0.00056	CcSEcCtD
Zanamivir—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.00039	0.00056	CcSEcCtD
Zanamivir—Dizziness—Zonisamide—epilepsy syndrome	0.00039	0.00056	CcSEcCtD
Zanamivir—Headache—Diazepam—epilepsy syndrome	0.00039	0.00056	CcSEcCtD
Zanamivir—Anxiety—Pregabalin—epilepsy syndrome	0.000389	0.000558	CcSEcCtD
Zanamivir—Diarrhoea—Clonazepam—epilepsy syndrome	0.000389	0.000558	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000387	0.000556	CcSEcCtD
Zanamivir—Asthenia—Carbamazepine—epilepsy syndrome	0.000386	0.000555	CcSEcCtD
Zanamivir—Agitation—Gabapentin—epilepsy syndrome	0.000386	0.000554	CcSEcCtD
Zanamivir—Diarrhoea—Phenytoin—epilepsy syndrome	0.000386	0.000554	CcSEcCtD
Zanamivir—Discomfort—Pregabalin—epilepsy syndrome	0.000385	0.000553	CcSEcCtD
Zanamivir—Nausea—Fosphenytoin—epilepsy syndrome	0.000385	0.000553	CcSEcCtD
Zanamivir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000384	0.000551	CcSEcCtD
Zanamivir—Erythema multiforme—Topiramate—epilepsy syndrome	0.000384	0.000551	CcSEcCtD
Zanamivir—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000383	0.000551	CcSEcCtD
Zanamivir—Vomiting—Felbamate—epilepsy syndrome	0.000383	0.00055	CcSEcCtD
Zanamivir—Rash—Felbamate—epilepsy syndrome	0.00038	0.000545	CcSEcCtD
Zanamivir—Dermatitis—Felbamate—epilepsy syndrome	0.000379	0.000545	CcSEcCtD
Zanamivir—Malaise—Gabapentin—epilepsy syndrome	0.000379	0.000544	CcSEcCtD
Zanamivir—Headache—Felbamate—epilepsy syndrome	0.000377	0.000542	CcSEcCtD
Zanamivir—Confusional state—Pregabalin—epilepsy syndrome	0.000377	0.000541	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000377	0.000541	CcSEcCtD
Zanamivir—Syncope—Gabapentin—epilepsy syndrome	0.000377	0.000541	CcSEcCtD
Zanamivir—Dizziness—Clonazepam—epilepsy syndrome	0.000376	0.000539	CcSEcCtD
Zanamivir—Nausea—Vigabatrin—epilepsy syndrome	0.000375	0.000539	CcSEcCtD
Zanamivir—Vomiting—Zonisamide—epilepsy syndrome	0.000375	0.000538	CcSEcCtD
Zanamivir—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000374	0.000537	CcSEcCtD
Zanamivir—Asthenia—Lamotrigine—epilepsy syndrome	0.000373	0.000536	CcSEcCtD
Zanamivir—Dizziness—Phenytoin—epilepsy syndrome	0.000373	0.000536	CcSEcCtD
Zanamivir—Rash—Zonisamide—epilepsy syndrome	0.000372	0.000534	CcSEcCtD
Zanamivir—Infection—Pregabalin—epilepsy syndrome	0.000371	0.000534	CcSEcCtD
Zanamivir—Dermatitis—Zonisamide—epilepsy syndrome	0.000371	0.000533	CcSEcCtD
Zanamivir—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000371	0.000533	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	0.00037	0.00122	CbGpPWpGaD
Zanamivir—Nausea—Diazepam—epilepsy syndrome	0.000369	0.000531	CcSEcCtD
Zanamivir—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000369	0.00053	CcSEcCtD
Zanamivir—Headache—Zonisamide—epilepsy syndrome	0.000369	0.00053	CcSEcCtD
Zanamivir—NEU2—Metabolism—CYP2D6—epilepsy syndrome	0.000369	0.00121	CbGpPWpGaD
Zanamivir—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000369	0.00053	CcSEcCtD
Zanamivir—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000368	0.000529	CcSEcCtD
Zanamivir—Shock—Pregabalin—epilepsy syndrome	0.000368	0.000528	CcSEcCtD
Zanamivir—Cough—Gabapentin—epilepsy syndrome	0.000367	0.000527	CcSEcCtD
Zanamivir—Chills—Topiramate—epilepsy syndrome	0.000364	0.000523	CcSEcCtD
Zanamivir—Convulsion—Gabapentin—epilepsy syndrome	0.000364	0.000523	CcSEcCtD
Zanamivir—Skin disorder—Pregabalin—epilepsy syndrome	0.000363	0.000522	CcSEcCtD
Zanamivir—Vomiting—Clonazepam—epilepsy syndrome	0.000361	0.000519	CcSEcCtD
Zanamivir—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00036	0.000516	CcSEcCtD
Zanamivir—Vomiting—Phenytoin—epilepsy syndrome	0.000359	0.000515	CcSEcCtD
Zanamivir—Rash—Clonazepam—epilepsy syndrome	0.000358	0.000514	CcSEcCtD
Zanamivir—Dermatitis—Clonazepam—epilepsy syndrome	0.000358	0.000514	CcSEcCtD
Zanamivir—Myalgia—Gabapentin—epilepsy syndrome	0.000358	0.000514	CcSEcCtD
Zanamivir—Arthralgia—Gabapentin—epilepsy syndrome	0.000358	0.000514	CcSEcCtD
Zanamivir—Nausea—Felbamate—epilepsy syndrome	0.000358	0.000514	CcSEcCtD
Zanamivir—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000357	0.000512	CcSEcCtD
Zanamivir—Fatigue—Valproic Acid—epilepsy syndrome	0.000357	0.000512	CcSEcCtD
Zanamivir—Anxiety—Gabapentin—epilepsy syndrome	0.000356	0.000512	CcSEcCtD
Zanamivir—Anorexia—Pregabalin—epilepsy syndrome	0.000356	0.000512	CcSEcCtD
Zanamivir—Dizziness—Carbamazepine—epilepsy syndrome	0.000356	0.000511	CcSEcCtD
Zanamivir—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000356	0.000511	CcSEcCtD
Zanamivir—Headache—Clonazepam—epilepsy syndrome	0.000356	0.000511	CcSEcCtD
Zanamivir—Rash—Phenytoin—epilepsy syndrome	0.000356	0.000511	CcSEcCtD
Zanamivir—Dermatitis—Phenytoin—epilepsy syndrome	0.000355	0.00051	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000355	0.00051	CcSEcCtD
Zanamivir—Rash—Oxcarbazepine—epilepsy syndrome	0.000354	0.000508	CcSEcCtD
Zanamivir—Pain—Valproic Acid—epilepsy syndrome	0.000354	0.000508	CcSEcCtD
Zanamivir—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000354	0.000508	CcSEcCtD
Zanamivir—Headache—Phenytoin—epilepsy syndrome	0.000353	0.000508	CcSEcCtD
Zanamivir—Discomfort—Gabapentin—epilepsy syndrome	0.000353	0.000508	CcSEcCtD
Zanamivir—Headache—Oxcarbazepine—epilepsy syndrome	0.000352	0.000505	CcSEcCtD
Zanamivir—NEU2—Metabolism—ADRA2A—epilepsy syndrome	0.000351	0.00116	CbGpPWpGaD
Zanamivir—NEU2—Metabolism of proteins—POMC—epilepsy syndrome	0.000351	0.00115	CbGpPWpGaD
Zanamivir—Nausea—Zonisamide—epilepsy syndrome	0.00035	0.000503	CcSEcCtD
Zanamivir—NEU2—Metabolism—BCHE—epilepsy syndrome	0.00035	0.00115	CbGpPWpGaD
Zanamivir—Confusional state—Gabapentin—epilepsy syndrome	0.000346	0.000497	CcSEcCtD
Zanamivir—Dizziness—Lamotrigine—epilepsy syndrome	0.000344	0.000494	CcSEcCtD
Zanamivir—NEU2—Metabolism of proteins—CCL2—epilepsy syndrome	0.000343	0.00113	CbGpPWpGaD
Zanamivir—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000343	0.000492	CcSEcCtD
Zanamivir—Vomiting—Carbamazepine—epilepsy syndrome	0.000342	0.000492	CcSEcCtD
Zanamivir—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000341	0.000489	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.000341	0.000489	CcSEcCtD
Zanamivir—Infection—Gabapentin—epilepsy syndrome	0.000341	0.000489	CcSEcCtD
Zanamivir—Rash—Carbamazepine—epilepsy syndrome	0.00034	0.000488	CcSEcCtD
Zanamivir—Dermatitis—Carbamazepine—epilepsy syndrome	0.000339	0.000487	CcSEcCtD
Zanamivir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000338	0.000486	CcSEcCtD
Zanamivir—Nausea—Clonazepam—epilepsy syndrome	0.000337	0.000485	CcSEcCtD
Zanamivir—Headache—Carbamazepine—epilepsy syndrome	0.000337	0.000485	CcSEcCtD
Zanamivir—Shock—Gabapentin—epilepsy syndrome	0.000337	0.000484	CcSEcCtD
Zanamivir—Nausea—Phenytoin—epilepsy syndrome	0.000335	0.000481	CcSEcCtD
Zanamivir—NEU2—Metabolism—SLC2A1—epilepsy syndrome	0.000334	0.0011	CbGpPWpGaD
Zanamivir—Dyspnoea—Pregabalin—epilepsy syndrome	0.000333	0.000479	CcSEcCtD
Zanamivir—Nausea—Oxcarbazepine—epilepsy syndrome	0.000333	0.000479	CcSEcCtD
Zanamivir—Skin disorder—Gabapentin—epilepsy syndrome	0.000333	0.000478	CcSEcCtD
Zanamivir—Vomiting—Lamotrigine—epilepsy syndrome	0.000331	0.000475	CcSEcCtD
Zanamivir—NEU2—Metabolism—PLCB1—epilepsy syndrome	0.00033	0.00109	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—TH—epilepsy syndrome	0.000329	0.00108	CbGpPWpGaD
Zanamivir—Urticaria—Valproic Acid—epilepsy syndrome	0.000329	0.000472	CcSEcCtD
Zanamivir—Rash—Lamotrigine—epilepsy syndrome	0.000328	0.000471	CcSEcCtD
Zanamivir—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000328	0.000471	CcSEcCtD
Zanamivir—Dermatitis—Lamotrigine—epilepsy syndrome	0.000328	0.000471	CcSEcCtD
Zanamivir—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000327	0.00047	CcSEcCtD
Zanamivir—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000327	0.00047	CcSEcCtD
Zanamivir—Anorexia—Gabapentin—epilepsy syndrome	0.000327	0.000469	CcSEcCtD
Zanamivir—Headache—Lamotrigine—epilepsy syndrome	0.000326	0.000468	CcSEcCtD
Zanamivir—Decreased appetite—Pregabalin—epilepsy syndrome	0.000325	0.000467	CcSEcCtD
Zanamivir—Agitation—Topiramate—epilepsy syndrome	0.000325	0.000466	CcSEcCtD
Zanamivir—NEU2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	0.000324	0.00107	CbGpPWpGaD
Zanamivir—Fatigue—Pregabalin—epilepsy syndrome	0.000322	0.000463	CcSEcCtD
Zanamivir—Nausea—Carbamazepine—epilepsy syndrome	0.00032	0.000459	CcSEcCtD
Zanamivir—Pain—Pregabalin—epilepsy syndrome	0.00032	0.000459	CcSEcCtD
Zanamivir—Malaise—Topiramate—epilepsy syndrome	0.000319	0.000458	CcSEcCtD
Zanamivir—Syncope—Topiramate—epilepsy syndrome	0.000317	0.000455	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000312	0.000449	CcSEcCtD
Zanamivir—Loss of consciousness—Topiramate—epilepsy syndrome	0.000311	0.000446	CcSEcCtD
Zanamivir—Nausea—Lamotrigine—epilepsy syndrome	0.000309	0.000444	CcSEcCtD
Zanamivir—Cough—Topiramate—epilepsy syndrome	0.000308	0.000443	CcSEcCtD
Zanamivir—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000308	0.000443	CcSEcCtD
Zanamivir—Convulsion—Topiramate—epilepsy syndrome	0.000306	0.00044	CcSEcCtD
Zanamivir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000306	0.000439	CcSEcCtD
Zanamivir—Dyspnoea—Gabapentin—epilepsy syndrome	0.000306	0.000439	CcSEcCtD
Zanamivir—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000305	0.000438	CcSEcCtD
Zanamivir—Myalgia—Topiramate—epilepsy syndrome	0.000301	0.000432	CcSEcCtD
Zanamivir—Arthralgia—Topiramate—epilepsy syndrome	0.000301	0.000432	CcSEcCtD
Zanamivir—Anxiety—Topiramate—epilepsy syndrome	0.0003	0.000431	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000299	0.000429	CcSEcCtD
Zanamivir—Decreased appetite—Gabapentin—epilepsy syndrome	0.000298	0.000428	CcSEcCtD
Zanamivir—Discomfort—Topiramate—epilepsy syndrome	0.000297	0.000427	CcSEcCtD
Zanamivir—Urticaria—Pregabalin—epilepsy syndrome	0.000297	0.000427	CcSEcCtD
Zanamivir—Asthenia—Valproic Acid—epilepsy syndrome	0.000297	0.000426	CcSEcCtD
Zanamivir—Fatigue—Gabapentin—epilepsy syndrome	0.000296	0.000425	CcSEcCtD
Zanamivir—Abdominal pain—Pregabalin—epilepsy syndrome	0.000296	0.000425	CcSEcCtD
Zanamivir—Body temperature increased—Pregabalin—epilepsy syndrome	0.000296	0.000425	CcSEcCtD
Zanamivir—Pain—Gabapentin—epilepsy syndrome	0.000293	0.000421	CcSEcCtD
Zanamivir—Confusional state—Topiramate—epilepsy syndrome	0.000291	0.000418	CcSEcCtD
Zanamivir—Infection—Topiramate—epilepsy syndrome	0.000287	0.000412	CcSEcCtD
Zanamivir—Shock—Topiramate—epilepsy syndrome	0.000284	0.000408	CcSEcCtD
Zanamivir—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000283	0.000406	CcSEcCtD
Zanamivir—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000283	0.000406	CcSEcCtD
Zanamivir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.00028	0.000403	CcSEcCtD
Zanamivir—Skin disorder—Topiramate—epilepsy syndrome	0.00028	0.000402	CcSEcCtD
Zanamivir—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000275	0.000396	CcSEcCtD
Zanamivir—Anorexia—Topiramate—epilepsy syndrome	0.000275	0.000395	CcSEcCtD
Zanamivir—NEU2—Metabolism—HMOX1—epilepsy syndrome	0.000274	0.000903	CbGpPWpGaD
Zanamivir—Dizziness—Valproic Acid—epilepsy syndrome	0.000273	0.000393	CcSEcCtD
Zanamivir—Urticaria—Gabapentin—epilepsy syndrome	0.000272	0.000391	CcSEcCtD
Zanamivir—Abdominal pain—Gabapentin—epilepsy syndrome	0.000271	0.000389	CcSEcCtD
Zanamivir—Body temperature increased—Gabapentin—epilepsy syndrome	0.000271	0.000389	CcSEcCtD
Zanamivir—NEU2—Metabolism—CAT—epilepsy syndrome	0.000271	0.000891	CbGpPWpGaD
Zanamivir—Asthenia—Pregabalin—epilepsy syndrome	0.000268	0.000385	CcSEcCtD
Zanamivir—NEU2—Metabolism—ABCB1—epilepsy syndrome	0.000263	0.000867	CbGpPWpGaD
Zanamivir—Vomiting—Valproic Acid—epilepsy syndrome	0.000263	0.000378	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000263	0.000377	CcSEcCtD
Zanamivir—Rash—Valproic Acid—epilepsy syndrome	0.000261	0.000375	CcSEcCtD
Zanamivir—Dermatitis—Valproic Acid—epilepsy syndrome	0.000261	0.000374	CcSEcCtD
Zanamivir—Headache—Valproic Acid—epilepsy syndrome	0.000259	0.000372	CcSEcCtD
Zanamivir—Dyspnoea—Topiramate—epilepsy syndrome	0.000257	0.000369	CcSEcCtD
Zanamivir—Diarrhoea—Pregabalin—epilepsy syndrome	0.000256	0.000367	CcSEcCtD
Zanamivir—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000253	0.000363	CcSEcCtD
Zanamivir—Decreased appetite—Topiramate—epilepsy syndrome	0.000251	0.00036	CcSEcCtD
Zanamivir—Fatigue—Topiramate—epilepsy syndrome	0.000249	0.000357	CcSEcCtD
Zanamivir—Dizziness—Pregabalin—epilepsy syndrome	0.000247	0.000355	CcSEcCtD
Zanamivir—Pain—Topiramate—epilepsy syndrome	0.000247	0.000354	CcSEcCtD
Zanamivir—Asthenia—Gabapentin—epilepsy syndrome	0.000246	0.000353	CcSEcCtD
Zanamivir—Nausea—Valproic Acid—epilepsy syndrome	0.000246	0.000353	CcSEcCtD
Zanamivir—NEU2—Metabolism—GPX1—epilepsy syndrome	0.000245	0.000806	CbGpPWpGaD
Zanamivir—Vomiting—Pregabalin—epilepsy syndrome	0.000238	0.000341	CcSEcCtD
Zanamivir—Feeling abnormal—Topiramate—epilepsy syndrome	0.000238	0.000341	CcSEcCtD
Zanamivir—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000236	0.000339	CcSEcCtD
Zanamivir—Rash—Pregabalin—epilepsy syndrome	0.000236	0.000339	CcSEcCtD
Zanamivir—Dermatitis—Pregabalin—epilepsy syndrome	0.000236	0.000338	CcSEcCtD
Zanamivir—Diarrhoea—Gabapentin—epilepsy syndrome	0.000235	0.000337	CcSEcCtD
Zanamivir—Headache—Pregabalin—epilepsy syndrome	0.000234	0.000336	CcSEcCtD
Zanamivir—Urticaria—Topiramate—epilepsy syndrome	0.000229	0.000329	CcSEcCtD
Zanamivir—Abdominal pain—Topiramate—epilepsy syndrome	0.000228	0.000328	CcSEcCtD
Zanamivir—Body temperature increased—Topiramate—epilepsy syndrome	0.000228	0.000328	CcSEcCtD
Zanamivir—Dizziness—Gabapentin—epilepsy syndrome	0.000227	0.000326	CcSEcCtD
Zanamivir—Nausea—Pregabalin—epilepsy syndrome	0.000222	0.000319	CcSEcCtD
Zanamivir—Vomiting—Gabapentin—epilepsy syndrome	0.000218	0.000313	CcSEcCtD
Zanamivir—Rash—Gabapentin—epilepsy syndrome	0.000216	0.00031	CcSEcCtD
Zanamivir—Dermatitis—Gabapentin—epilepsy syndrome	0.000216	0.00031	CcSEcCtD
Zanamivir—Headache—Gabapentin—epilepsy syndrome	0.000215	0.000308	CcSEcCtD
Zanamivir—NEU2—Metabolism—AGT—epilepsy syndrome	0.000215	0.000707	CbGpPWpGaD
Zanamivir—Hypersensitivity—Topiramate—epilepsy syndrome	0.000213	0.000305	CcSEcCtD
Zanamivir—NEU2—Metabolism—APOE—epilepsy syndrome	0.00021	0.000692	CbGpPWpGaD
Zanamivir—Asthenia—Topiramate—epilepsy syndrome	0.000207	0.000297	CcSEcCtD
Zanamivir—Nausea—Gabapentin—epilepsy syndrome	0.000204	0.000292	CcSEcCtD
Zanamivir—Diarrhoea—Topiramate—epilepsy syndrome	0.000197	0.000283	CcSEcCtD
Zanamivir—Dizziness—Topiramate—epilepsy syndrome	0.000191	0.000274	CcSEcCtD
Zanamivir—Vomiting—Topiramate—epilepsy syndrome	0.000183	0.000263	CcSEcCtD
Zanamivir—Rash—Topiramate—epilepsy syndrome	0.000182	0.000261	CcSEcCtD
Zanamivir—Dermatitis—Topiramate—epilepsy syndrome	0.000182	0.000261	CcSEcCtD
Zanamivir—Headache—Topiramate—epilepsy syndrome	0.000181	0.00026	CcSEcCtD
Zanamivir—NEU2—Metabolism—POMC—epilepsy syndrome	0.000181	0.000595	CbGpPWpGaD
Zanamivir—Nausea—Topiramate—epilepsy syndrome	0.000171	0.000246	CcSEcCtD
Zanamivir—NEU2—Metabolism—ALB—epilepsy syndrome	0.000165	0.000542	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—PTGS2—epilepsy syndrome	0.000144	0.000474	CbGpPWpGaD
Zanamivir—NEU2—Metabolism—AKT1—epilepsy syndrome	7.24e-05	0.000238	CbGpPWpGaD
